A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-07

AUTHORS

Gordana Vlahovic, Kellen L. Meadows, Hope E. Uronis, Michael A. Morse, Gerard C. Blobe, Richard F. Riedel, S. Yousuf Zafar, Angeles Alvarez-Secord, Jon Gockerman, Alexander N. Starodub, Neal E. Ready, Elizabeth L. Anderson, Johanna C. Bendell, Herbert I. Hurwitz

ABSTRACT

PURPOSE: Preclinical data suggest concurrent inhibition of VEGF, mTOR and EGFR pathways may augment antitumor and antiangiogenic effects compared to inhibition of each pathway alone. This study evaluated the maximum tolerated dose/recommended phase II dose and safety and tolerability of bevacizumab, everolimus and panitumumab drug combination. METHODS: Subjects with advanced solid tumors received escalating doses of everolimus and flat dosing of panitumumab at 4.8 mg/kg and bevacizumab at 10 mg/kg every 2 weeks. Dose-limiting toxicities (DLTs) were assessed in cycle 1; toxicity evaluation was closely monitored throughout treatment. Treatment continued until disease progression or undesirable toxicity. RESULTS: Thirty-two subjects were evaluable for toxicity; 31 subjects were evaluable for tumor response. DLTs were observed in cohorts with everolimus at 10 and 5 mg daily and included grade 3 mucositis, skin rash and thrombocytopenia. Therefore, everolimus was dose-reduced to 5 mg three times weekly, which improved the tolerability of the treatment regimen. Common adverse events were skin rash/pruritus (91 %), mucositis/stomatitis (75 %), hypomagnesemia (72 %), hypocalcemia (56 %) and hypokalemia (50 %). There were 3 partial responses; an additional 10 subjects had stable disease ≥6 months. Three subjects with ovarian cancer and one with endometrial cancer achieved prolonged disease control ranging from 11 to >40 months. CONCLUSIONS: The recommended phase II dose is everolimus at 5 mg three times weekly plus panitumumab at 4.8 mg/kg and bevacizumab at 10 mg/kg every 2 weeks. This dosing regimen has an acceptable safety and tolerability profile and appears to have moderate the clinical activity in refractory tumors. More... »

PAGES

95-102

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-012-1889-8

DOI

http://dx.doi.org/10.1007/s00280-012-1889-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014306924

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22638798


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Everolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Exanthema", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypocalcemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypokalemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mucositis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sirolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vlahovic", 
        "givenName": "Gordana", 
        "id": "sg:person.015243435602.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015243435602.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meadows", 
        "givenName": "Kellen L.", 
        "id": "sg:person.014460031617.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014460031617.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Uronis", 
        "givenName": "Hope E.", 
        "id": "sg:person.01257037273.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257037273.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morse", 
        "givenName": "Michael A.", 
        "id": "sg:person.013700705377.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blobe", 
        "givenName": "Gerard C.", 
        "id": "sg:person.0754271650.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754271650.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Riedel", 
        "givenName": "Richard F.", 
        "id": "sg:person.0603256347.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603256347.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zafar", 
        "givenName": "S. Yousuf", 
        "id": "sg:person.01110705575.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110705575.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alvarez-Secord", 
        "givenName": "Angeles", 
        "id": "sg:person.0713447463.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713447463.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gockerman", 
        "givenName": "Jon", 
        "id": "sg:person.0663550257.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663550257.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Goshen Health", 
          "id": "https://www.grid.ac/institutes/grid.490115.8", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA", 
            "Goshen Center for Cancer Care, 46526, Goshen, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Starodub", 
        "givenName": "Alexander N.", 
        "id": "sg:person.013456341506.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013456341506.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ready", 
        "givenName": "Neal E.", 
        "id": "sg:person.0707715501.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707715501.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anderson", 
        "givenName": "Elizabeth L.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sarah Cannon", 
          "id": "https://www.grid.ac/institutes/grid.419513.b", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA", 
            "Sarah Cannon Research Institute, 37203, Nashville, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bendell", 
        "givenName": "Johanna C.", 
        "id": "sg:person.01174064377.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174064377.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hurwitz", 
        "givenName": "Herbert I.", 
        "id": "sg:person.01242177577.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242177577.68"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/(sici)1097-4652(199902)178:2<235::aid-jcp13>3.0.co;2-s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002861600"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1541-7786.mcr-06-0404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002862384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.22.20.7004-7014.2002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003444276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-06-0166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004420604"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.01.8234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005188382"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.01.8234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005188382"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2583", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005785818", 
          "https://doi.org/10.1038/nrc2583"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-05-1554", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006168874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.20.0766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006224899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drup.2007.11.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006901712"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.05361", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009596453"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/erc.0.0100203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013016361"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/erc.0.0100203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013016361"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra0707704", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013325677"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.hoc.2004.06.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014250661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0202-128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015189512", 
          "https://doi.org/10.1038/nm0202-128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0202-128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015189512", 
          "https://doi.org/10.1038/nm0202-128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/5042", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015487157", 
          "https://doi.org/10.1038/5042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/5042", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015487157", 
          "https://doi.org/10.1038/5042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra0706596", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021959499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-010-1507-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024060636", 
          "https://doi.org/10.1007/s00280-010-1507-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-010-1307-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029072898", 
          "https://doi.org/10.1007/s00280-010-1307-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-010-1307-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029072898", 
          "https://doi.org/10.1007/s00280-010-1307-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmct0807960", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031023635"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0603-669", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031340920", 
          "https://doi.org/10.1038/nm0603-669"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0603-669", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031340920", 
          "https://doi.org/10.1038/nm0603-669"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-06-0007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031639815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.477", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035414798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-07-0237", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038240570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.11.924", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038491362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.gene.2005.10.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038589426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molmed.2007.08.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039046675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.12.8637", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039829431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2007.05.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043775174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-4490", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045611231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-06-0416", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046442333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-2057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051117294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/89.15.1138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052997391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.06.081", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204278"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074801175", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076995655", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-07", 
    "datePublishedReg": "2012-07-01", 
    "description": "PURPOSE: Preclinical data suggest concurrent inhibition of VEGF, mTOR and EGFR pathways may augment antitumor and antiangiogenic effects compared to inhibition of each pathway alone. This study evaluated the maximum tolerated dose/recommended phase II dose and safety and tolerability of bevacizumab, everolimus and panitumumab drug combination.\nMETHODS: Subjects with advanced solid tumors received escalating doses of everolimus and flat dosing of panitumumab at 4.8 mg/kg and bevacizumab at 10 mg/kg every 2 weeks. Dose-limiting toxicities (DLTs) were assessed in cycle 1; toxicity evaluation was closely monitored throughout treatment. Treatment continued until disease progression or undesirable toxicity.\nRESULTS: Thirty-two subjects were evaluable for toxicity; 31 subjects were evaluable for tumor response. DLTs were observed in cohorts with everolimus at 10 and 5 mg daily and included grade 3 mucositis, skin rash and thrombocytopenia. Therefore, everolimus was dose-reduced to 5 mg three times weekly, which improved the tolerability of the treatment regimen. Common adverse events were skin rash/pruritus (91 %), mucositis/stomatitis (75 %), hypomagnesemia (72 %), hypocalcemia (56 %) and hypokalemia (50 %). There were 3 partial responses; an additional 10 subjects had stable disease \u22656 months. Three subjects with ovarian cancer and one with endometrial cancer achieved prolonged disease control ranging from 11 to >40 months.\nCONCLUSIONS: The recommended phase II dose is everolimus at 5 mg three times weekly plus panitumumab at 4.8 mg/kg and bevacizumab at 10 mg/kg every 2 weeks. This dosing regimen has an acceptable safety and tolerability profile and appears to have moderate the clinical activity in refractory tumors.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-012-1889-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2420933", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "70"
      }
    ], 
    "name": "A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors", 
    "pagination": "95-102", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "44284e51ff0cc5c5df0e957097835caa0a790d173d4b1ba4c675b53a05a1b5e1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22638798"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-012-1889-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014306924"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-012-1889-8", 
      "https://app.dimensions.ai/details/publication/pub.1014306924"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000487.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00280-012-1889-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-012-1889-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-012-1889-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-012-1889-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-012-1889-8'


 

This table displays all metadata directly associated to this object as RDF triples.

365 TRIPLES      21 PREDICATES      86 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-012-1889-8 schema:about N183d290054e14a36b8ad1518c417c4aa
2 N18538cebc0d540d082e1785cc8a6c2ae
3 N1c89c45f3fde48bdbfeced89b57372bc
4 N24b9e45c99724cf99a7f4ea9bcaacef7
5 N29ecf76482814a029409539340671748
6 N2ea124b7b1ef4cae8ec9186df273014e
7 N365e9dd44f5e4a9eb92686a99e2684d1
8 N57421c244939452fb764f5f9b8a573aa
9 N5f8276ce5fac4cf59381b6a437904447
10 N66b8da171f2142e3a987d25f8d469490
11 N6aa4eb577204499fbf89e01678eecfd0
12 N6d2c124a56fc4754b1103d91a8a568c1
13 N7e61399cdda54684b9d10b45b81b1d85
14 N80067f947c7a4b40861b65a93af958ff
15 N8640818322894b05b445f919970f0b4b
16 N908cc613de9c481ba1022f6cf0cd44e6
17 Nc400cc8c8aa94be795a913b0f805be3c
18 Nc5e95f55ba784b8da30d0518d1190c65
19 Nc87bd1a69add4889b2ecab985d95b138
20 Nf738b50cfecb4e32875c5cb843aa6b80
21 Nfaafbfffb7f34feb9bd378c8fa7a6f9f
22 anzsrc-for:11
23 anzsrc-for:1103
24 schema:author N367e493822e94fabba4513ac05916850
25 schema:citation sg:pub.10.1007/s00280-010-1307-z
26 sg:pub.10.1007/s00280-010-1507-6
27 sg:pub.10.1038/5042
28 sg:pub.10.1038/nm0202-128
29 sg:pub.10.1038/nm0603-669
30 sg:pub.10.1038/nrc2583
31 https://app.dimensions.ai/details/publication/pub.1074801175
32 https://app.dimensions.ai/details/publication/pub.1076995655
33 https://doi.org/10.1002/(sici)1097-4652(199902)178:2<235::aid-jcp13>3.0.co;2-s
34 https://doi.org/10.1016/j.ccr.2007.05.008
35 https://doi.org/10.1016/j.drup.2007.11.003
36 https://doi.org/10.1016/j.gene.2005.10.018
37 https://doi.org/10.1016/j.hoc.2004.06.002
38 https://doi.org/10.1016/j.molmed.2007.08.001
39 https://doi.org/10.1056/nejmct0807960
40 https://doi.org/10.1056/nejmra0706596
41 https://doi.org/10.1056/nejmra0707704
42 https://doi.org/10.1093/jnci/89.15.1138
43 https://doi.org/10.1093/jnci/92.11.924
44 https://doi.org/10.1093/jnci/92.3.205
45 https://doi.org/10.1128/mcb.22.20.7004-7014.2002
46 https://doi.org/10.1158/0008-5472.can-06-4490
47 https://doi.org/10.1158/1078-0432.ccr-05-1554
48 https://doi.org/10.1158/1078-0432.ccr-08-2057
49 https://doi.org/10.1158/1535-7163.mct-06-0007
50 https://doi.org/10.1158/1535-7163.mct-06-0166
51 https://doi.org/10.1158/1535-7163.mct-06-0416
52 https://doi.org/10.1158/1535-7163.mct-07-0237
53 https://doi.org/10.1158/1541-7786.mcr-06-0404
54 https://doi.org/10.1200/jco.2005.01.8234
55 https://doi.org/10.1200/jco.2005.02.477
56 https://doi.org/10.1200/jco.2005.06.081
57 https://doi.org/10.1200/jco.2007.12.8637
58 https://doi.org/10.1200/jco.2008.20.0766
59 https://doi.org/10.1593/neo.05361
60 https://doi.org/10.1677/erc.0.0100203
61 schema:datePublished 2012-07
62 schema:datePublishedReg 2012-07-01
63 schema:description PURPOSE: Preclinical data suggest concurrent inhibition of VEGF, mTOR and EGFR pathways may augment antitumor and antiangiogenic effects compared to inhibition of each pathway alone. This study evaluated the maximum tolerated dose/recommended phase II dose and safety and tolerability of bevacizumab, everolimus and panitumumab drug combination. METHODS: Subjects with advanced solid tumors received escalating doses of everolimus and flat dosing of panitumumab at 4.8 mg/kg and bevacizumab at 10 mg/kg every 2 weeks. Dose-limiting toxicities (DLTs) were assessed in cycle 1; toxicity evaluation was closely monitored throughout treatment. Treatment continued until disease progression or undesirable toxicity. RESULTS: Thirty-two subjects were evaluable for toxicity; 31 subjects were evaluable for tumor response. DLTs were observed in cohorts with everolimus at 10 and 5 mg daily and included grade 3 mucositis, skin rash and thrombocytopenia. Therefore, everolimus was dose-reduced to 5 mg three times weekly, which improved the tolerability of the treatment regimen. Common adverse events were skin rash/pruritus (91 %), mucositis/stomatitis (75 %), hypomagnesemia (72 %), hypocalcemia (56 %) and hypokalemia (50 %). There were 3 partial responses; an additional 10 subjects had stable disease ≥6 months. Three subjects with ovarian cancer and one with endometrial cancer achieved prolonged disease control ranging from 11 to >40 months. CONCLUSIONS: The recommended phase II dose is everolimus at 5 mg three times weekly plus panitumumab at 4.8 mg/kg and bevacizumab at 10 mg/kg every 2 weeks. This dosing regimen has an acceptable safety and tolerability profile and appears to have moderate the clinical activity in refractory tumors.
64 schema:genre research_article
65 schema:inLanguage en
66 schema:isAccessibleForFree true
67 schema:isPartOf Nd2c396750f74484ba1d64b2641a6c26d
68 Ne2aef57c272e42b9ac7c258b0a0f691a
69 sg:journal.1088364
70 schema:name A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
71 schema:pagination 95-102
72 schema:productId N338d483661d4497fba64275f8db55ec4
73 N484cce22750d4b449595f3ceaa4f9489
74 N832d527c70a848a69827877213a44930
75 Nc346702be51843e19d1d706219ead60f
76 Ndcc4d32b3a3243bdb7723bb1d0518e65
77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014306924
78 https://doi.org/10.1007/s00280-012-1889-8
79 schema:sdDatePublished 2019-04-10T21:31
80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
81 schema:sdPublisher Nf2611b5688834428a15a7692e016de2c
82 schema:url http://link.springer.com/10.1007/s00280-012-1889-8
83 sgo:license sg:explorer/license/
84 sgo:sdDataset articles
85 rdf:type schema:ScholarlyArticle
86 N0d88c8659729433a9f5a839fa222449b rdf:first sg:person.013456341506.33
87 rdf:rest N26fe5fb84bae42de9b51dea89081f051
88 N117561d90de646e68bf22e4d66a35887 rdf:first sg:person.01242177577.68
89 rdf:rest rdf:nil
90 N183d290054e14a36b8ad1518c417c4aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Dose-Response Relationship, Drug
92 rdf:type schema:DefinedTerm
93 N18538cebc0d540d082e1785cc8a6c2ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Humans
95 rdf:type schema:DefinedTerm
96 N1c89c45f3fde48bdbfeced89b57372bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Aged
98 rdf:type schema:DefinedTerm
99 N24229d7e4ddf4990b828b7bec79744a6 rdf:first sg:person.0663550257.48
100 rdf:rest N0d88c8659729433a9f5a839fa222449b
101 N24b9e45c99724cf99a7f4ea9bcaacef7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Antineoplastic Combined Chemotherapy Protocols
103 rdf:type schema:DefinedTerm
104 N26fe5fb84bae42de9b51dea89081f051 rdf:first sg:person.0707715501.98
105 rdf:rest N5d288d79c82f4e759095ac57a0960445
106 N29ecf76482814a029409539340671748 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Bevacizumab
108 rdf:type schema:DefinedTerm
109 N2ea124b7b1ef4cae8ec9186df273014e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Exanthema
111 rdf:type schema:DefinedTerm
112 N338d483661d4497fba64275f8db55ec4 schema:name readcube_id
113 schema:value 44284e51ff0cc5c5df0e957097835caa0a790d173d4b1ba4c675b53a05a1b5e1
114 rdf:type schema:PropertyValue
115 N365e9dd44f5e4a9eb92686a99e2684d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Treatment Outcome
117 rdf:type schema:DefinedTerm
118 N367e493822e94fabba4513ac05916850 rdf:first sg:person.015243435602.40
119 rdf:rest N45609e3d60ed4fe48bdc6e8455a6840e
120 N45609e3d60ed4fe48bdc6e8455a6840e rdf:first sg:person.014460031617.65
121 rdf:rest N4d91c624bb924755bc432fa717a24565
122 N484cce22750d4b449595f3ceaa4f9489 schema:name nlm_unique_id
123 schema:value 7806519
124 rdf:type schema:PropertyValue
125 N4d91c624bb924755bc432fa717a24565 rdf:first sg:person.01257037273.91
126 rdf:rest Nc7236a9b1ed14e36ade92356a2ecaf7e
127 N57421c244939452fb764f5f9b8a573aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Hypokalemia
129 rdf:type schema:DefinedTerm
130 N5d288d79c82f4e759095ac57a0960445 rdf:first Na88bbc1a896c4370bf5ede2c5c227957
131 rdf:rest N89f80bf0a4c3436bbd799cf8e6196884
132 N5f8276ce5fac4cf59381b6a437904447 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Everolimus
134 rdf:type schema:DefinedTerm
135 N65217ea8867d4bd6b25ddda8246c6195 rdf:first sg:person.01110705575.00
136 rdf:rest N9b2d58e555ab472fa19221b6d3ff4910
137 N66b8da171f2142e3a987d25f8d469490 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Sirolimus
139 rdf:type schema:DefinedTerm
140 N6aa4eb577204499fbf89e01678eecfd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Antibodies, Monoclonal, Humanized
142 rdf:type schema:DefinedTerm
143 N6d2c124a56fc4754b1103d91a8a568c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Female
145 rdf:type schema:DefinedTerm
146 N7e61399cdda54684b9d10b45b81b1d85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Adult
148 rdf:type schema:DefinedTerm
149 N80067f947c7a4b40861b65a93af958ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Middle Aged
151 rdf:type schema:DefinedTerm
152 N832d527c70a848a69827877213a44930 schema:name doi
153 schema:value 10.1007/s00280-012-1889-8
154 rdf:type schema:PropertyValue
155 N8640818322894b05b445f919970f0b4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Mucositis
157 rdf:type schema:DefinedTerm
158 N89f80bf0a4c3436bbd799cf8e6196884 rdf:first sg:person.01174064377.38
159 rdf:rest N117561d90de646e68bf22e4d66a35887
160 N908cc613de9c481ba1022f6cf0cd44e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Antibodies, Monoclonal
162 rdf:type schema:DefinedTerm
163 N9b2d58e555ab472fa19221b6d3ff4910 rdf:first sg:person.0713447463.37
164 rdf:rest N24229d7e4ddf4990b828b7bec79744a6
165 Na35e0f45adff456493abf2c14091bedb rdf:first sg:person.0754271650.99
166 rdf:rest Nfec5edacaa8649db9c833fef8b5da35f
167 Na88bbc1a896c4370bf5ede2c5c227957 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
168 schema:familyName Anderson
169 schema:givenName Elizabeth L.
170 rdf:type schema:Person
171 Nc346702be51843e19d1d706219ead60f schema:name dimensions_id
172 schema:value pub.1014306924
173 rdf:type schema:PropertyValue
174 Nc400cc8c8aa94be795a913b0f805be3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Male
176 rdf:type schema:DefinedTerm
177 Nc5e95f55ba784b8da30d0518d1190c65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Neoplasms
179 rdf:type schema:DefinedTerm
180 Nc7236a9b1ed14e36ade92356a2ecaf7e rdf:first sg:person.013700705377.06
181 rdf:rest Na35e0f45adff456493abf2c14091bedb
182 Nc87bd1a69add4889b2ecab985d95b138 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Young Adult
184 rdf:type schema:DefinedTerm
185 Nd2c396750f74484ba1d64b2641a6c26d schema:volumeNumber 70
186 rdf:type schema:PublicationVolume
187 Ndcc4d32b3a3243bdb7723bb1d0518e65 schema:name pubmed_id
188 schema:value 22638798
189 rdf:type schema:PropertyValue
190 Ne2aef57c272e42b9ac7c258b0a0f691a schema:issueNumber 1
191 rdf:type schema:PublicationIssue
192 Nf2611b5688834428a15a7692e016de2c schema:name Springer Nature - SN SciGraph project
193 rdf:type schema:Organization
194 Nf738b50cfecb4e32875c5cb843aa6b80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Hypocalcemia
196 rdf:type schema:DefinedTerm
197 Nfaafbfffb7f34feb9bd378c8fa7a6f9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Drug Administration Schedule
199 rdf:type schema:DefinedTerm
200 Nfec5edacaa8649db9c833fef8b5da35f rdf:first sg:person.0603256347.24
201 rdf:rest N65217ea8867d4bd6b25ddda8246c6195
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
206 schema:name Clinical Sciences
207 rdf:type schema:DefinedTerm
208 sg:grant.2420933 http://pending.schema.org/fundedItem sg:pub.10.1007/s00280-012-1889-8
209 rdf:type schema:MonetaryGrant
210 sg:journal.1088364 schema:issn 0344-5704
211 1432-0843
212 schema:name Cancer Chemotherapy and Pharmacology
213 rdf:type schema:Periodical
214 sg:person.01110705575.00 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
215 schema:familyName Zafar
216 schema:givenName S. Yousuf
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110705575.00
218 rdf:type schema:Person
219 sg:person.01174064377.38 schema:affiliation https://www.grid.ac/institutes/grid.419513.b
220 schema:familyName Bendell
221 schema:givenName Johanna C.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174064377.38
223 rdf:type schema:Person
224 sg:person.01242177577.68 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
225 schema:familyName Hurwitz
226 schema:givenName Herbert I.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242177577.68
228 rdf:type schema:Person
229 sg:person.01257037273.91 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
230 schema:familyName Uronis
231 schema:givenName Hope E.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257037273.91
233 rdf:type schema:Person
234 sg:person.013456341506.33 schema:affiliation https://www.grid.ac/institutes/grid.490115.8
235 schema:familyName Starodub
236 schema:givenName Alexander N.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013456341506.33
238 rdf:type schema:Person
239 sg:person.013700705377.06 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
240 schema:familyName Morse
241 schema:givenName Michael A.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06
243 rdf:type schema:Person
244 sg:person.014460031617.65 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
245 schema:familyName Meadows
246 schema:givenName Kellen L.
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014460031617.65
248 rdf:type schema:Person
249 sg:person.015243435602.40 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
250 schema:familyName Vlahovic
251 schema:givenName Gordana
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015243435602.40
253 rdf:type schema:Person
254 sg:person.0603256347.24 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
255 schema:familyName Riedel
256 schema:givenName Richard F.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603256347.24
258 rdf:type schema:Person
259 sg:person.0663550257.48 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
260 schema:familyName Gockerman
261 schema:givenName Jon
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663550257.48
263 rdf:type schema:Person
264 sg:person.0707715501.98 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
265 schema:familyName Ready
266 schema:givenName Neal E.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707715501.98
268 rdf:type schema:Person
269 sg:person.0713447463.37 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
270 schema:familyName Alvarez-Secord
271 schema:givenName Angeles
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713447463.37
273 rdf:type schema:Person
274 sg:person.0754271650.99 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
275 schema:familyName Blobe
276 schema:givenName Gerard C.
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754271650.99
278 rdf:type schema:Person
279 sg:pub.10.1007/s00280-010-1307-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1029072898
280 https://doi.org/10.1007/s00280-010-1307-z
281 rdf:type schema:CreativeWork
282 sg:pub.10.1007/s00280-010-1507-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024060636
283 https://doi.org/10.1007/s00280-010-1507-6
284 rdf:type schema:CreativeWork
285 sg:pub.10.1038/5042 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015487157
286 https://doi.org/10.1038/5042
287 rdf:type schema:CreativeWork
288 sg:pub.10.1038/nm0202-128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015189512
289 https://doi.org/10.1038/nm0202-128
290 rdf:type schema:CreativeWork
291 sg:pub.10.1038/nm0603-669 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031340920
292 https://doi.org/10.1038/nm0603-669
293 rdf:type schema:CreativeWork
294 sg:pub.10.1038/nrc2583 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005785818
295 https://doi.org/10.1038/nrc2583
296 rdf:type schema:CreativeWork
297 https://app.dimensions.ai/details/publication/pub.1074801175 schema:CreativeWork
298 https://app.dimensions.ai/details/publication/pub.1076995655 schema:CreativeWork
299 https://doi.org/10.1002/(sici)1097-4652(199902)178:2<235::aid-jcp13>3.0.co;2-s schema:sameAs https://app.dimensions.ai/details/publication/pub.1002861600
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1016/j.ccr.2007.05.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043775174
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1016/j.drup.2007.11.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006901712
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1016/j.gene.2005.10.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038589426
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1016/j.hoc.2004.06.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014250661
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1016/j.molmed.2007.08.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039046675
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1056/nejmct0807960 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031023635
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1056/nejmra0706596 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021959499
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1056/nejmra0707704 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013325677
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1093/jnci/89.15.1138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052997391
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1093/jnci/92.11.924 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038491362
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1128/mcb.22.20.7004-7014.2002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003444276
324 rdf:type schema:CreativeWork
325 https://doi.org/10.1158/0008-5472.can-06-4490 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045611231
326 rdf:type schema:CreativeWork
327 https://doi.org/10.1158/1078-0432.ccr-05-1554 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006168874
328 rdf:type schema:CreativeWork
329 https://doi.org/10.1158/1078-0432.ccr-08-2057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051117294
330 rdf:type schema:CreativeWork
331 https://doi.org/10.1158/1535-7163.mct-06-0007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031639815
332 rdf:type schema:CreativeWork
333 https://doi.org/10.1158/1535-7163.mct-06-0166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004420604
334 rdf:type schema:CreativeWork
335 https://doi.org/10.1158/1535-7163.mct-06-0416 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046442333
336 rdf:type schema:CreativeWork
337 https://doi.org/10.1158/1535-7163.mct-07-0237 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038240570
338 rdf:type schema:CreativeWork
339 https://doi.org/10.1158/1541-7786.mcr-06-0404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002862384
340 rdf:type schema:CreativeWork
341 https://doi.org/10.1200/jco.2005.01.8234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005188382
342 rdf:type schema:CreativeWork
343 https://doi.org/10.1200/jco.2005.02.477 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035414798
344 rdf:type schema:CreativeWork
345 https://doi.org/10.1200/jco.2005.06.081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204278
346 rdf:type schema:CreativeWork
347 https://doi.org/10.1200/jco.2007.12.8637 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039829431
348 rdf:type schema:CreativeWork
349 https://doi.org/10.1200/jco.2008.20.0766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006224899
350 rdf:type schema:CreativeWork
351 https://doi.org/10.1593/neo.05361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009596453
352 rdf:type schema:CreativeWork
353 https://doi.org/10.1677/erc.0.0100203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013016361
354 rdf:type schema:CreativeWork
355 https://www.grid.ac/institutes/grid.189509.c schema:alternateName Duke University Hospital
356 schema:name Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA
357 rdf:type schema:Organization
358 https://www.grid.ac/institutes/grid.419513.b schema:alternateName Sarah Cannon
359 schema:name Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA
360 Sarah Cannon Research Institute, 37203, Nashville, TN, USA
361 rdf:type schema:Organization
362 https://www.grid.ac/institutes/grid.490115.8 schema:alternateName Goshen Health
363 schema:name Duke University Medical Center, Seeley G. Mudd Bldg, 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA
364 Goshen Center for Cancer Care, 46526, Goshen, IN, USA
365 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...